We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISCA
1451
DELISTED
International Speedway Corp
ISCA
| $1.85M | 0.01% |
56,810
+2,900
| +5% | +$90.4K |
|
1452
Novavax
NVAX
$1.27B
| $1.84M | 0.01% |
11,149
+2,084
| +23% | +$338K |
|
1453
Independent Bank
INDB
$4.08B
| $1.84M | 0.01% |
41,961
+1,975
| +5% | +$81.3K |
|
1454
Nektar Therapeutics
NKTR
$2.47B
| $1.84M | 0.01% |
11,147
+850
| +8% | +$175K |
|
1455
Lindsay Corp
LNN
$1.17B
| $1.84M | 0.01% |
24,090
+1,100
| +5% | +$92.4K |
|
1456
Nelnet
NNI
$4.89B
| $1.83M | 0.01% |
38,725
+100
| +0.3% | +$4.61K |
|
|
WBMD
1457
DELISTED
WebMD Health Corp.
WBMD
| $1.83M | 0.01% |
41,779
+6,285
| +18% | +$261K |
|
|
RTI
1458
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $1.83M | 0.01% |
50,899
+910
| +2% | +$25.5K |
|
1459
Ironwood Pharmaceuticals
IRWD
$683M
| $1.83M | 0.01% |
136,275
+24,459
| +22% | +$321K |
|
1460
Otter Tail
OTTR
$3.9B
| $1.82M | 0.01% |
56,690
+1,300
| +2% | +$41.4K |
|
|
EXPR
1461
DELISTED
Express, Inc.
EXPR
| $1.82M | 0.01% |
5,519
+182
| +3% | +$52.7K |
|
1462
Scholastic
SCHL
$801M
| $1.82M | 0.01% |
44,518
+1,100
| +3% | +$40.7K |
|
1463
Ligand Pharmaceuticals
LGND
$6.06B
| $1.82M | 0.01% |
37,828
+3,759
| +11% | +$144K |
|
1464
FirstCash
FCFS
$9.02B
| $1.82M | 0.01% |
39,100
+4,375
| +13% | +$218K |
|
1465
HUB Group
HUBG
$2.91B
| $1.82M | 0.01% |
92,548
+9,300
| +11% | +$175K |
|
|
HZNP
1466
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.81M | 0.01% |
69,891
+17,795
| +34% | +$326K |
|
1467
TotalEnergies
TTE
$188B
| $1.81M | 0.01% |
23,126,299,892
+637,910,099
| +3% | +$63.8K |
|
|
CVA
1468
DELISTED
Covanta Holding Corporation
CVA
| $1.81M | 0.01% |
80,670
+280
| +0.3% | +$6K |
|
1469
Choice Hotels
CHH
$5.09B
| $1.81M | 0.01% |
28,226
+1,015
| +4% | +$61.8K |
|
1470
NETGEAR
NTGR
$659M
| $1.81M | 0.01% |
54,981
-610
| -1% | -$20.2K |
|
1471
Five Below
FIVE
$12.4B
| $1.81M | 0.01% |
50,793
+8,000
| +19% | +$267K |
|
1472
Scansource
SCSC
$1.17B
| $1.81M | 0.01% |
44,435
+1,410
| +3% | +$53.4K |
|
1473
E.W. Scripps
SSP
$263M
| $1.8M | 0.01% |
71,430
+1,792
| +3% | +$36K |
|
|
CMO
1474
DELISTED
Capstead Mortgage Corp.
CMO
| $1.8M | 0.01% |
153,079
+8,300
| +6% | +$99.9K |
|
|
ENV
1475
DELISTED
ENVESTNET, INC.
ENV
| $1.8M | 0.01% |
32,091
+4,870
| +18% | +$260K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.